NCT01258998 2020-11-04Study of Akt Inhibitor MK2206 in Patients With Relapsed LymphomaNational Cancer Institute (NCI)Phase 2 Completed60 enrolled 8 charts
NCT01231919 2014-04-29MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or LeukemiaNational Cancer Institute (NCI)Phase 1 Completed45 enrolled